Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity Post author: Post published:December 1, 2023 Post category:uncategorized The impact of semaglutide and tirzepatide and glucagon-like peptide-1 receptor agonist medications on alcohol consumption. You Might Also Like Brain cells form multiple coordinate systems to guide behavioral actions November 6, 2024 Is posttraumatic epilepsy associated with long-term dementia risk? March 1, 2024 Study shows how heteroresistance can act as a precursor to antibiotic resistance March 18, 2024